Webinars
Women in BioPharma Awards 2021
Summary: Join us as we honor a group of 20 extraordinary women who are making lasting impacts in the drug development field.
View Now
Podcast
Leveraging N-1 Perfusion for Higher Productivity and Quality for Biologics
Summary: Join Claudia Berdugo, Ph.D., Director of Process Development at Catalent Biologics, for a podcast where she discusses N-1 perfusion and how Catalent Biologics works toward process improvements....
View Now
Video
An Interview: Potential of iPSCs
Summary: In this informative interview with Phacilitate, Boris Greber and Thomas Marx answer questions about the position of induced pluripotent stem cells in today’s advanced therapies market and the transformative power latent in their clinical application.
View Now
eBook
Cellular Starting Materials In Focus
Summary: In this ebook, we bring you expert insights into the advantages that various cellular starting materials have, with a particular focus on human induced pluripotent stem cells (iPSCs).
View Now
Infographic
Features of iPSCs as Starting Materials
Summary: How can using iPSCs as starting materials help with transforming cell therapies into standard care? This infographic highlights the key features of iPSCs as starting materials, from donor consent through to commercial innovation.
View Now
Webinars
Strategies to Accelerate the Path to Clinic for Next-Generation Antibodies
Summary: Experts discuss formulation development and purification strategies to increase throughput, reduce operating costs and decrease...
View Now
Webinars
Webinar: Developing the Next Big Vaccine Technologies
Summary: In this panel discussion, Endpoints News publisher, Arsalan Arif convenes some of the field's top experts to discuss...
View Now
Article
What’s Next for mRNA? From COVID to Cancer & Beyond
Summary: During this Q&A, we discuss the challenges of mRNA development and manufacturing, potential solutions and where the industry may go next with mRNA therapies.
View Now
Executive Summary
The Path to Self-Administration: Considerations for Moving from Pre-Filled Syringe to Auto-Injector
Summary: In this executive summary, Catalent Biologics offers advice to pharma companies on three key areas of auto-injector device development.
View Now
Webinars
Leveraging Proven Technology to Speed Path to First-In-Human Studies with GPEx® Lightning
Summary: During this talk, hear the latest data leveraging GPEx Lightning to generate highly stable, highly productive cell pools and discuss how the GPEx...
View Now